Phoenix NLME statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.

Subscribe
info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Population PK/PD modeling chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

Phoenix NLME specifications

Information


Unique identifier OMICS_16894
Name Phoenix NLME
Software type Package/Module
Interface Graphical user interface
Operating system Unix/Linux, Mac OS, Windows
License Commercial, Other
Computer skills Medium
Stability Stable
Maintained Yes

Versioning


Add your version

Documentation


Maintainer


  • person_outline Phoenix NLME Team <>

Phoenix NLME in publications

 (24)
PMCID: 5948273
PMID: 29423715
DOI: 10.1007/s00198-018-4376-1

[…] − 2.5 were estimated against three categories of tracp-5b decreases (100, 200, and 300 mu/dl)., all modeling and simulation in this study were performed using a nonlinear mixed-effects modeling in phoenix nlme 1.3 software (pharsight corporation, certara, lp, princeton, nj) with the foce-els algorithm., data from a total of 306 patients who had values for at least one bone resorption marker […]

PMCID: 5688484
PMID: 29143669
DOI: 10.1186/s13071-017-2449-1

[…] higher than the fed dogs []. population pharmacokinetic analysis, using nonlinear mixed effects modeling (nlme, phoenix software, https://www.certara.com/software/pkpd-modeling-and-simulation/phoenix-nlme/) showed that feeding has a significant effect on the variability of oral absorption in dogs [].fig. 1 , minocycline and doxycycline have broad antibacterial activity that includes […]

PMCID: 5667771
PMID: 29095954
DOI: 10.1371/journal.pone.0187624

[…] was used for data analysis., nonlinear mixed effects modeling was performed to estimate the pharmacokinetics parameters []. model development used first-order conditional estimation (foce) in phoenix nlme 7.0 (certara) to provide estimates of the typical values for population pharmacokinetic parameters, between-subject variability, inter-occasional variability, and residual variability., […]

PMCID: 5612971
PMID: 28947805
DOI: 10.1038/s41598-017-12159-z

[…] plasma concentration–time data were analysed by nonlinear mixed-effects regression using first-order conditional estimation with extended least squares (foce-els) as an estimation method in phoenix nlme® (certara, cary, nc, usa). values below the loq were excluded from the data set prior to data summarization and pharmacokinetic analysis. the structural pk model for the iv data […]

PMCID: 5613187
PMID: 28643370
DOI: 10.1002/psp4.12220

[…] s exponential and residual error as additive. 6mwt(1) = intercept + slope∗exp(ηslope)∗age. 6mwt(2) = intercept2 + slope2∗exp(ηslope2)∗age. , 6mwt = min (6mwt(1),6mwt(2)); min = minimizing function in phoenix nlme., for each individual, the age at maximum response (agemax) is the x value (agemax) at which the two lines intersect (6mwt(1) = 6mwt(2)). agemax= (intercept2−intercept)/(slope∗exp(ηslope) […]


To access a full list of publications, you will need to upgrade to our premium service.

Phoenix NLME reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Phoenix NLME